Roberta Duncan, Seqirus mRNA program head (Seqirus)
CSL's Seqirus, spurred on by Covid-19 mRNA vaccines, props up new unit for 'self-amplifying' shot tech
The Covid-19 pandemic has offered proof of concept for the promise of mRNA vaccines, and now CSL Behring’s Seqirus unit wants to take the next …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
